Expanding Insurance Coverage Many countries are gradually including GLP-1 therapies in reimbursement policies, driving accessibility
USA 118 , e2022614118 (2021)
If severe or persistent gastrointestinal symptoms occur, especially with signs of dehydration, discontinue use and consult a healthcare provider
PLEASE NOTE THAT the packaging appearance of the item may not be exactly the same as shown in the pictures as the manufacture may change the look of the packaging every now and then
But after that [time], no matter what I did, I couldnt [lose any more weight]
If an athlete was competing while intoxicated I can see the argument against that, but at the very least were in an area where the merits of whether or not something should be on the list are debatable